{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:48:59Z","timestamp":1776235739966,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018641","name":"University of Otago Division of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.parkreldis.2025.108149","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:53:04Z","timestamp":1765299184000},"page":"108149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Plasma microRNA predict cognitive decline in Parkinson's disease"],"prefix":"10.1016","volume":"143","author":[{"given":"D.","family":"Gu\u00e9vremont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-5727","authenticated-orcid":false,"given":"C.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cutfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-2220","authenticated-orcid":false,"given":"J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2025.108149_bib1","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson's disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2025.108149_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2025.108149_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","article-title":"Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health","volume":"4","author":"Goldman","year":"2018","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2025.108149_bib4","article-title":"Dalrymple-Alford, J.C. different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal study","volume":"2","author":"Wood","year":"2016","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2025.108149_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-017-0085-5","article-title":"Caregiver burden is increased in Parkinson's disease with mild cognitive impairment (PD-MCI)","volume":"6","author":"Jones","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.parkreldis.2025.108149_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mdc3.13451","article-title":"Level I PD-MCI using global cognitive tests and the risk for Parkinson's disease dementia","volume":"9","author":"Boel","year":"2022","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2025.108149_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1474-4422(23)00503-3","article-title":"Has the time come to redefine Parkinson's disease?","volume":"23","author":"Darweesh","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib9","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1093\/brain\/awad265","article-title":"How should we be using biomarkers in trials of disease modification in Parkinson's disease?","volume":"146","author":"Vijiaratnam","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2025.108149_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417544","article-title":"Biological diagnosis of Alzheimer's disease based on amyloid status: an illustration of confirmation bias in medical research?","volume":"24","author":"Souchet","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parkreldis.2025.108149_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41531-024-00791-2","article-title":"MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets","volume":"10","author":"Shaheen","year":"2024","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2025.108149_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43096-9","article-title":"MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis","volume":"13","author":"Gu\u00e9vremont","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2025.108149_bib14","article-title":"Plasma microRNA vary in association with the progression of Alzheimer's disease","volume":"14","author":"Gu\u00e9vremont","year":"2022","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.parkreldis.2025.108149_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215403","article-title":"Meta-analysis of gene expression changes in the blood of patients with mild cognitive impairment and Alzheimer's disease dementia","volume":"20","author":"Bottero","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parkreldis.2025.108149_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fneur.2020.00288","article-title":"The regulation of microRNAs in Alzheimer's disease","volume":"11","author":"Kou","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuroscience.2025.01.038","article-title":"MicroRNAs in Parkinson's disease: from pathogenesis to diagnostics and therapeutic strategies","volume":"568","author":"Zheng","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2025.108149_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1397106","article-title":"MicroRNAs regulating autophagy: opportunities in treating neurodegenerative diseases","volume":"18","author":"Mohseni","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.parkreldis.2025.108149_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.pmbts.2016.12.013","article-title":"MicroRNAs as peripheral biomarkers in aging and age-related diseases","volume":"146","author":"Kumar","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.parkreldis.2025.108149_bib20","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2025.108149_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141815","article-title":"Alteration of brain functional networks in early-stage Parkinson's disease: a resting-state fMRI study","volume":"10","author":"Sang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2025.108149_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137887","article-title":"miR-142-3p alleviates neuronal apoptosis in Parkinson's disease via negatively regulating C9orf72","volume":"836","author":"Meng","year":"2024","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2025.108149_bib23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s12035-023-03629-9","article-title":"Astrocytic extracellular vesicles regulated by microglial inflammatory responses improve stroke recovery","volume":"61","author":"Kijima","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib24","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.18632\/aging.202466","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1\/TRAF6 signaling pathway after ischemic stroke","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.parkreldis.2025.108149_bib25","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1007\/s10571-023-01362-4","article-title":"Yadav, S. Transcriptomics and proteomics approach for the identification of altered blood microRNAs and plasma proteins in Parkinson's disease","volume":"43","author":"Yadav","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson's disease in women and men: what's the difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2025.108149_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010911","article-title":"Blood-based biomarkers in Alzheimer's disease: advancing non-invasive diagnostics and prognostics","volume":"25","author":"Dhauria","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parkreldis.2025.108149_bib28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2013.3646","article-title":"Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications","volume":"70","author":"Butcher","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A MicroRNA feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.parkreldis.2025.108149_bib30","doi-asserted-by":"crossref","first-page":"C624","DOI":"10.1152\/ajpcell.00303.2020","article-title":"miRNA degradation in the mammalian brain","volume":"319","author":"Kim","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12043","article-title":"RNA packaging into extracellular vesicles: an orchestra of RNA-binding proteins?","volume":"10","author":"Fabbiano","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.parkreldis.2025.108149_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040857","article-title":"RNA-binding protein motifs predict microRNA secretion and cellular retention in hypothalamic and other cell types","volume":"12","author":"He","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.parkreldis.2025.108149_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib34","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1093\/nar\/gkq601","article-title":"Export of microRNAs and microRNA-protective protein by mammalian cells","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.parkreldis.2025.108149_bib35","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.parkreldis.2025.108149_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biom14081030","article-title":"Extracellular vesicles induce nuclear Factor-\u03baB activation and Interleukin-8 synthesis through miRNA-191-5p contributing to inflammatory processes: potential implications in the pathogenesis of chronic obstructive pulmonary disease","volume":"14","author":"Carpi","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.parkreldis.2025.108149_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.614068","article-title":"Emerging role of MiR-192-5p in human diseases","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2018.12.015","article-title":"Baicalin alleviates 6-hydroxydopamine-induced neurotoxicity in PC12 cells by down-regulation of microRNA-192-5p","volume":"1708","author":"Kang","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.parkreldis.2025.108149_bib39","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1002\/alz.14197","article-title":"Blood-derived microRNAs are related to cognitive domains in the general population","volume":"20","author":"Melas","year":"2024","journal-title":"Alzheimer's Dementia : J. Alzheimer's Assoc."},{"key":"10.1016\/j.parkreldis.2025.108149_bib40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1096\/fj.201800210RR","article-title":"Up-regulated miR-192-5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2-mediated TGF-\u03b21 signaling pathway","volume":"33","author":"Tang","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.parkreldis.2025.108149_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.mad.2012.09.004","article-title":"Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging","volume":"133","author":"Olivieri","year":"2012","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.parkreldis.2025.108149_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.compbiolchem.2018.12.011","article-title":"Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease","volume":"78","author":"Rahman","year":"2019","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.parkreldis.2025.108149_bib43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fnins.2020.00438","article-title":"Differential expression of plasma Exo-miRNA in neurodegenerative diseases by next-generation sequencing","volume":"14","author":"Nie","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.parkreldis.2025.108149_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104587","article-title":"Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against \u03b2-amyloid by targeting DAPK-1 and TP53","volume":"118","author":"Guo","year":"2021","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5607\/en20014","article-title":"Death-associated protein kinase 1 phosphorylates \u03b1-Synuclein at Ser129 and exacerbates rotenone-induced toxic aggregation of \u03b1-Synuclein in dopaminergic SH-SY5Y cells","volume":"29","author":"Shin","year":"2020","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib46","article-title":"Microglia-derived exosomal microRNA-151-3p enhances functional healing after spinal cord injury by attenuating neuronal apoptosis via regulating the p53\/p21\/CDK1 signaling pathway","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.parkreldis.2025.108149_bib47","doi-asserted-by":"crossref","first-page":"12678","DOI":"10.1080\/21655979.2021.2008638","article-title":"MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease","volume":"12","author":"Wan","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.parkreldis.2025.108149_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1152\/physiolgenomics.00133.2016","article-title":"MiR-146a\/b: a family with shared seeds and different roots","volume":"49","author":"Paterson","year":"2017","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.parkreldis.2025.108149_bib49","first-page":"3078","article-title":"MicroRNA-146a inhibits NF-\u03baB activation and pro-inflammatory cytokine production by regulating IRAK1 expression in THP-1 cells","volume":"18","author":"Zhou","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.parkreldis.2025.108149_bib50","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1080\/15548627.2023.2196889","article-title":"CircEPS15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy","volume":"19","author":"Zhou","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.parkreldis.2025.108149_bib51","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4161\/auto.7.5.14811","article-title":"Systems biology of the autophagy-lysosomal pathway","volume":"7","author":"Jegga","year":"2011","journal-title":"Autophagy"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802025008983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802025008983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:52:14Z","timestamp":1768837934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802025008983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":51,"alternative-id":["S1353802025008983"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.108149","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma microRNA predict cognitive decline in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.108149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108149"}}